Skip to main content

Table 1 Synergists and corresponding doses used for the experiments

From: Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study

Drug

Mechanism of action

D A (C max) (ng/ml)

D B (75% of C max) (ng/ml)

DC (50% of C max) (ng/ml)

D D (25% of C max) (ng/ml)

Cobicistat [31]

Dual CYP/P-gp inhibitora

990

742

495

247

Cyclosporine A [32]

Selective P-gp inhibitorb

1802

1351

901

450

Elacridar [33]

Selective P-gp inhibitor

160

120

80

40

Rifampicin [34]

Dual CYP/P-gp inducer

7000

5250

3500

1750

Ritonavir [35]

Dual CYP/P-gp inhibitor

11,000

8250

5500

2750

Voriconazole [36]

Dual CYP/P-gp inhibitor

3667

2750

1833

916

  1. aWith effect markedly skewed towards CYP inhibition
  2. bNegligible effect on CYPs